Low homoarginine/SDMA ratio is associated with poor short- and long-term outcome after stroke in two prospective studies.
Chi-Un ChoeSusanne LeziusKathrin CordtsChristian GerloffRainer H BögerEdzard SchwedhelmPeter J GrantPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2019)
These results from two prospective stroke studies reveal that hArg/SDMA ratio could prove a valuable blood-based biomarker to discriminate patients with poor short- and long-term outcome, increased neurological impairment, and severe disability after stroke.